Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Allergic Reactions

Allergic Reactions

What is the Immune System?

What is the Immune System?

Humoral Immune Responses

Humoral Immune Responses

Reaction Mechanisms

Reaction Mechanisms

Chemical reactions often occur in a stepwise fashion, involving two or more distinct reactions taking place in a sequence. A balanced equation indicates the reacting species and the product species, but it reveals no details about how the reaction occurs at the molecular level. The reaction mechanism (or reaction path) provides details regarding the precise, step-by-step process by which a reaction occurs.
For instance, the decomposition of ozone appears to follow a mechanism with two steps:

Determining Order of Reaction

Determining Order of Reaction

Rate laws describe the relationship between the rate of a chemical reaction and the concentration of its reactants. In a rate law, the rate constant k and the reaction orders are determined experimentally by observing how the rate of reaction changes as the concentrations of the reactants are changed. A common experimental approach to the determination of rate laws is the method of initial rates. This method involves measuring reaction rates for multiple experimental trials carried out using...

Reaction Yield

Reaction Yield

The theoretical yield of a reaction is the amount of product estimated to form based on the stoichiometry of the balanced chemical equation. The theoretical yield assumes the complete conversion of the limiting reactant into the desired product. The amount of product that is obtained by performing the reaction is called the actual yield, and it may be less than or (very rarely) equal to the theoretical yield.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Face/off: phase-specific modeling of lineage plasticity using near-patient models in genitourinary cancers.

Gene·2026

Same author

The Association Between Number of Hospital Advanced Practice Providers and Surgical Morbidity.

Cancer medicine·2026

Same author

Understanding randomized controlled trial generalizability through an embedded molecular diagnostics trial.

JNCI cancer spectrum·2026

Same author

Game of clones: decipher lineage plasticity in hormone-driven cancers.

Cellular and molecular life sciences : CMLS·2026

Same author

Systemic Treatments in Men with De Novo Metastatic Prostate Cancer.

The Urologic clinics of North America·2026

Same author

Moving the Needle in Managing Men with Advanced Prostate Cancer.

The Urologic clinics of North America·2026

Search research articles

Related Experiment Video

Updated: Jan 24, 2026

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

Immune reaction by cytoreductive prostatectomy.

Geun Taek Lee¹, Arnav Srivastava¹, Young Suk Kwon¹

¹Section of Urologic Oncology, Rutgers Cancer Institute of New Jersey, and Division of Urology, Rutgers Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey New Brunswick, NJ, USA.

American Journal of Clinical and Experimental Urology

|May 30, 2019

Summary

Cytoreductive prostatectomy (CRP) shows survival benefits for advanced prostate cancer. Further research is needed on its immunologic effects and combination with immunotherapy for better metastatic disease treatment.

Keywords:

Prostate cancer cytoreductive metastasis radical prostatectomy

More Related Videos

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy

Published on: December 28, 2021

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors

Published on: June 7, 2018

Related Experiment Videos

Last Updated: Jan 24, 2026

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy

Published on: December 28, 2021

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors

Published on: June 7, 2018

Area of Science:

Oncology
Immunology

Background:

Prostate cancer (PCa) is a leading cause of cancer death in men, with poor survival rates for advanced and metastatic castration-resistant prostate cancer (mCRPC).
Current treatments like hormonal manipulation, immunotherapy, and chemotherapy offer limited efficacy, highlighting the need for novel therapeutic strategies.

Purpose of the Study:

To review the immunologic changes following cytoreductive prostatectomy (CRP) in patients with metastatic castration-resistant prostate cancer.
To explore the impact of these immunologic changes on oncologic outcomes.

Main Methods:

Literature review focusing on studies investigating immunologic responses post-CRP.
Analysis of existing data on the efficacy and safety of CRP for mCRPC.

Main Results:

Cytoreductive prostatectomy (CRP) is an emerging treatment modality for mCRPC with demonstrated survival benefits.
There is limited published data specifically detailing the immunological alterations induced by CRP.

Conclusions:

CRP is a promising treatment for various metastatic cancers, with ongoing technical advancements.
CRP combined with immunotherapy represents a developing treatment approach for metastatic disease, warranting further investigation into its immunological effects.